Evidence map›Paper›PMID 28665971›Full record

ArticlePloS one2017

Biophysical induction of cell release for minimally manipulative cell enrichment strategies.

Pascal Joly, Thomas Schaus, Andrea Sass, Anke Dienelt, Alexander S Cheung, Georg N Duda, David J Mooney

Abstract readValidation Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pascal JolyWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, United States of America.ORCID http://orcid.org/0000-0002-8079-5004
Thomas SchausWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, United States of America.
Andrea SassJulius Wolff Institute and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Anke DieneltJulius Wolff Institute and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Alexander S CheungWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, United States of America.
Georg N DudaWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, United States of America.
David J MooneyWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of autologous cells harvested and subsequently transplanted in an intraoperative environment constitutes a new approach to promote regeneration. Usually cells are isolated by selection methods such as fluorescence- or magnetic- activated cell sorting with residual binding of the antibodies or beads. Thus, cell-based therapies would benefit from the development of new devices for cell isolation that minimally manipulate the target cell population. In the clinic, 5 to 10 percent of fractures do not heal properly and CD31+ cells have been identified as promising candidates to support bone regeneration. The aim of this project was to develop and prototype a simple system to facilitate the enrichment of CD31+ cells from whole blood. After validating the specificity of a commercially available aptamer for CD31, we combined this aptamer with traditional magnetic bead strategies, which led to enrichment of CD31+ cells with a purity of 91±10%. Subsequently, the aptamer was attached to agarose beads (Ø = 100-165 um) that were incorporated into a column-based system to enable capture and subsequent release of the CD31+ enriched cells. Different parameters were investigated to allow a biophysical-based cell release from beads, and a simple mixing was found sufficient to release initially bound cells from the optimized column without the need for any chemicals that promote disassociation. The system led to a significant enrichment of CD31+ cells (initial population: 63±9%, released: 87±3%) with excellent cell viability (released: 97±1%). The composition of the released CD31+ fraction indicated an enrichment of the monocyte population. The angiogenic and osteogenic potential of the released cell population were confirmed in vitro. These results and the simplicity of this system highlight the potential of such approach to enable cell enrichment strategies in intraoperative settings.

Indexed as

Biophysical PhenomenaCulture Media, ConditionedFlow CytometryHumansHuman Umbilical Vein Endothelial CellsImmunomagnetic SeparationMonocytesNeovascularization, PhysiologicOsteogenesisPlatelet Endothelial Cell Adhesion Molecule-1Culture Media, ConditionedPlatelet Endothelial Cell Adhesion Molecule-1

Identifiers

PMID28665971
PMCPMC5493423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.